ZEPZELCA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Lurbinectedin.
Product ID | 68727-712_1539647e-08e6-449a-86f7-0d090dbeb698 |
NDC | 68727-712 |
Product Type | Human Prescription Drug |
Proprietary Name | ZEPZELCA |
Generic Name | Lurbinectedin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-06-15 |
Marketing Category | NDA / NDA |
Application Number | NDA213702 |
Labeler Name | Jazz Pharmaceuticals, Inc. |
Substance Name | LURBINECTEDIN |
Active Ingredient Strength | 1 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2020-06-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZEPZELCA 88916468 not registered Live/Pending |
PHARMA MAR, S.A. 2020-05-14 |
ZEPZELCA 88848581 not registered Live/Pending |
PHARMA MAR S.A. 2020-03-26 |
ZEPZELCA 88848557 not registered Live/Pending |
PHARMA MAR S.A. 2020-03-26 |